Skip to Content

尊敬的客户:

目前国际形势复杂多变,关税政策尚不明朗,这可能对我们的产品价格产生一定影响。在此情况下,我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性,如果您选择在此期间下单,我们将保留根据实际情况调整价格的权利。同时,我们也理解市场变化可能给您带来的困扰,因此如果在订单实际发货前因关税政策变动导致价格出现较大波动,默克将与您进行协商讨论并视情况对订单进行调整或取消。

关于应对近期政策变化的重要更新,请点击此处查看详情。

Merck
CN
HomeGene Expression & SilencingMISSION® shRNA Lentiviral Transduction

MISSION® shRNA Lentiviral Transduction

MISSION<sup>®</sup> shRNA Target Set

Figure 1.Five individual clones from MISSION® shRNA Target Set NM_002467 were co-transfected with a lentivirus packaging plasmid into HEK 293T cells. The resulting lentiviral particles were used to infect the human lung cancer cell line, H1299. 24 hours post-infection, 2.5 mg/mL of puromycin was added to select for infected cells. Infection efficiency was approximately 95%. 72 hours post-selection, cells were harvested. C-MYC message RNA level was detected by real-time PCR. Actin mRNA was used as an internal control.

c-MYC shRNA Target Set

Figure 2.Protein lysates from the shRNA infected cells were analyzed by western blotting using a c-MYC antibody. C-MYC protein levels corresponds to the mRNA knockdown shown in Figure 1.

Data generously provided by Dr. Steven B. McMahon, The Wistar Institute


Contact Us

For questions about the library, pricing and quotes or other concerns, please email us.

MISSION is a trademark of Merck KGaA, Darmstadt, Germany and/or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources. Label License.

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?